Invitation: Roche virtual late-stage oncology pipeline update at ASCO 2024 Mittwoch, 08. Mai 2024 - 14:51

We are pleased to invite investors and analysts to participate in our virtual event on Friday, 31 May 2024, highlighting Roche oncology products and late-stage pipeline assets for solid tumors and malignant hematology including data presented during the congress scientific program from May 31 – June 4, 2024.

16:00 – 17:00 CEST / 15:00 - 16:00 BST

09:00 – 10:00 am CDT / 7:00 – 8:00 am PDT

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:00 CEST on the day of the event. > click here

Access to virtual event (pre-registration required)

Please pre-register for our webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

A replay of the webcast will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Sabine Borngräber
Investor Relations Officer

Roche Investor Relations

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

Investor Relations North America

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com